Elizabeth Whittington

The website www.journeyforward.org was designed to help oncologists, primary care physicians and their patients improve their survivorship care.

ColoPrint gene assay can help guide treatment options for some colorectal patients, study shows.

Adolescents with AML tend to do better with stem cell transplant.

Online tool helps cancer survivors know what to look for years after treatment

Researchers showed that patients with nonsymptomatic, advanced follicular lymphoma (FL) benefit from Rituxan (rituximab) over watchful waiting.

A phase 2 trial presented at the American Society of Hematology in December could pave the way for a second approval for Istodax (romidepsin).

Study shows experimental drug ponatinib acts against a mutation found in small percentage of chronic myeloid leukemia cases that is resistant to other forms of therapy

Treatment differs for Acute myeloid leukemia pediatric patients compared with older adults.

Chronic myeloid leukemia (CML)usually can be managed as a chronic disease by therapies, including Gleevec (imatinib) or two newer drugs, Sprycel (dasatinib) or Tasigna (nilotinib).

For Hodgkin lymphoma patients who progress after a stem cell transplant, two new treatments may bring new hope.

Knowing the cellular basics drives treatment decisions.

News and perspectives from the breast cancer community.

Widespread genetic testing of Lynch syndrome is cost-efficient and reduces the risk of colorectal cancer.

In the NeoSphere study, various combinations of a new HER2-targeted agent called pertuzumab, Herceptin and chemothery were studied in early-stage breast cancer patients with encouraging results.